1Mount Sinai Hospital, University of Toronto, Toronto, Canada. hsteinhart@mtsinai.on.ca
For active Crohn's disease, various drugs offer symptom relief. However, for long-term remission, immunosuppressive agents and anti-TNF therapies show promise, while others have limited benefits or risks.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: